ArticleLung cancer (Amsterdam, Netherlands)2019

Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1-positive advanced non-small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies.

Kaname Nosaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.